United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 27, 2026 · Filed May 28, 2026

On May 27, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$575.40 for US$5.47M under a trading plan, leaving 40,513 shares. Filed May 28, 2026 (Form 4).

Sold
9,500 shares
Price
US$575.40 average (US$570.81 to US$579.59)
Value
US$5.47M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 27, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 27, 2026Common StockSale1,479US$570.8148,534Direct
May 27, 2026Common StockSale581US$571.5547,953Direct
May 27, 2026Common StockSale320US$572.4547,633Direct
May 27, 2026Common StockSale440US$574.2347,193Direct
May 27, 2026Common StockSale680US$575.5046,513Direct
May 27, 2026Common StockSale2,469US$576.2344,044Direct
May 27, 2026Common StockSale1,756US$577.2442,288Direct
May 27, 2026Common StockSale1,695US$578.2240,593Direct
May 27, 2026Common StockSale80US$579.5940,513Direct

Source

View original at SEC

Related